Kris Vezuli

He is a strategic thinker with scientific background and over 16 years of experience in drug development and commercialization. Kris has expertise in identifying, unlocking, and capturing value throughout the product life cycle in a variety of therapeutic areas, including rare diseases, autoimmune, oncology, central nervous system, renal, gastrointestinal and ophthalmology. His well-rounded expertise enables Kris to be a trusted thought partner of Value & Access and New Product Planning teams.